Nexium Buyers Win Class Cert In AstraZeneca Antitrust MDL
A Massachusetts federal judge certified a class of Nexium end-buyers on Thursday who accused AstraZeneca PLC and others of violating antitrust laws by delaying a generic version of AstraZeneca's heartburn drug,...To view the full article, register now.
Already a subscriber? Click here to view full article